Epstein-Barr Virus and Nasopharyngeal Carcinoma
Author Information
Author(s): J.R. Arrand, M. Mackett, E. Littler, Nick Day, Guy de The, Hans Wolf, Yi Zeng, Nancy Raab-Traub, Beverly Griffin, John Sixby, Beda Brichacek, Maria Lung, Anne Goodeve, Bengt Kallin, Lawrence Young, Martin Allday, Anthony Epstein, Andrew Morgan, Ling Chan, Mike Mackett, Nina Wedderburn, Alan Rickinson, David Tyrrell
Primary Institution: Paterson Institute for Cancer Research
Hypothesis
What is the precise role of Epstein-Barr Virus in the establishment and maintenance of nasopharyngeal carcinoma?
Conclusion
The symposium highlighted the complex interactions between Epstein-Barr Virus and various cofactors in the development of nasopharyngeal carcinoma.
Supporting Evidence
- EBV is associated with nasopharyngeal carcinoma, but its exact role is unclear.
- Certain HLA types are linked to a genetic predisposition to nasopharyngeal carcinoma.
- Ethnic differences in food habits may influence the frequency of nasopharyngeal carcinoma.
- EBV DNA can immortalize primary epithelial cells.
- EBV receptors have been found on epithelial cells.
- Elevated IgA antibodies against EBV early antigen may help in diagnosing nasopharyngeal carcinoma.
- Research is ongoing to develop a vaccine against EBV to prevent nasopharyngeal carcinoma.
Takeaway
Scientists are trying to understand how a virus called Epstein-Barr might cause a type of throat cancer, and they think other things like genetics and diet might also play a part.
Methodology
The meeting reviewed various studies and experiments related to the role of EBV in nasopharyngeal carcinoma.
Limitations
The difficulty in obtaining suitable samples for control experiments on biopsies from normal seronegatives.
Want to read the original?
Access the complete publication on the publisher's website